Aspirin Impact – Stable Coronary Artery Disease

Background

– Aspirin is recommended in stable coronary artery disease based on myocardial infarction and stroke studies. However, benefit among stable coronary artery disease patients who have not suffered an acute ischemic event is uncertain. The objective of this study was to evaluate the impact of aspirin in stable coronary artery disease. We hypothesized that aspirin’s benefit would be attenuated among individuals with stable coronary artery disease but no prior ischemic event.

Conclusion

In patients with stable coronary artery disease and hypertension, aspirin use was associated with reduced risk for adverse cardiovascular outcomes among those with prior ischemic events. Among patients with no prior ischemic events, aspirin use was not associated with a reduction in risk.

Read the full study here.

If you have been diagnosed with coronary heart disease, speak to your doctor to see if Aspirin is right for you.

Source: The American Journal of Medicine

Hocking Valley Medical Group

740-385-7564